Kalata B1

General Information


DCTPep ID  DCTPep00296

Peptide Name   Kalata B1

Sequence  GLPVCGETCVGGTCNTPGCTCSWPVCTRN

Sequence Length  29

UniProt ID  Not available

PubChem CID  Not available

Origin  Oldenlandia affinis; Viola yedoensis; Viola odorata; Viola baoshanensis

Type  Native peptide

Classification

  

ACP Tumor active peptide



Activity Information


Cell Line Disease Activity Assay Testing Time Literature
K562 Blast phase chronic myelogenous leukemia, BCR-ABL2 positive; Chronic myeloid leukemia 50% Cell death=13.1±0.4µM Resazurin assay 2, 24h 3
BGC-823 Human papillomavirus-related endocervical adenocarcinoma IC50=1.32±0.15µM SRB assay 48h 1
HeLa Human papillomavirus-related endocervical adenocarcinoma IC50=10.21±0.43µM MTT assay 5h 1
MM96L Melanoma IC50=3.10±0.06µM MTT assay 5h 1
U-937/GTB Adult acute monocytic leukemia; Acute monoblastic/monocytic leukemia IC50=6.9µM FMCA assay 72h 2

Hemolytic Activity  Human erythrocytes: Human erythrocytes: 41% Hemolysis=25 µM; Human erythrocytes: 50% Hemolysis=29.1±1.1 µM

Normal (non-cancerous) Cytotoxicity  HFF-1: IC50=2.38±0.09 µM; 50% Cell death=12.0±0.5 µM; CEM-SS cells: IC50=5.7 µM; Human PBMC: 50% Cell death=11.2±0.5 µM

Target  Not available

Affinity  Not available

Mechanism  Not available



Structure Information


PDB ID  Not available

Predicted Structure  DCTPep00296

(Please note that there is the predicted structure, predicted by AlphaFold)

Helicity  Not available

Linear/Cyclic  Cyclic

Disulfide/Other Bond  Cys5<--->Cys19; Cys9<--->Cys21; Cys14<--->Cys26; NCB: Gly1<--->Asn29

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C117H187N35O40S6

Absent amino acids  ADFHIKMQY

Theoretical pI  5.96

Acidic residues  1

Basic residues  1

Polar residues  19

Molecular weight (Average)  2916.34

Molecular weight (Monoisotopic)  2914.2

Common amino acids  C

Net charge  0

Instability index (II)  46.59

Aliphatic index  43.45

Grand average of hydropathicity (GRAVY)  0.152

Half Life 
  30 hours (mammalian reticulocytes, in vitro).
  >20 hours (yeast, in vivo).
  >10 hours (Escherichia coli, in vivo).

Extinction coefficients 
  Ext. coefficient 5875
  Abs 0.1% (=1 g/l) 2.015, assuming all pairs of Cys residues form cystines
  Ext. coefficient 5500
  Abs 0.1% (=1 g/l) 1.886, assuming all Cys residues are reduced

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 21723349

Title  Isolation and characterization of cytotoxic cyclotides from Viola philippica

Doi 10.1016/j.peptides.2011.06.016

Year  2011

Literature 2

Pubmed ID 28669767

Title  Bactericidal activity of cyclotides where phosphatidylethanolamine-lipid selectivity determines antimicrobial spectra

Doi 10.1016/j.bbamem.2017.06.018

Year  2017

Literature 3

Pubmed ID 25099014

Title  Anticancer and toxic properties of cyclotides are dependent on phosphatidylethanolamine phospholipid targeting

Doi 10.1002/cbic.201402144

Year  2014

Literature 4

Pubmed ID 21576247

Title  Decoding the membrane activity of the cyclotide kalata B1: the importance of phosphatidylethanolamine phospholipids and lipid organization on hemolytic and anti-HIV activities

Doi 10.1074/jbc.M111.253393

Year  2011

Literature 5

Pubmed ID 18081258

Title  Anti-HIV cyclotides from the Chinese medicinal herb Viola yedoensis

Doi 10.1021/np070393g

Year  2008

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DCTPep is developed by Dr.Zheng's team.